CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Sarepta Therapeutics, Inc.  (SRPT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

SRPT's Revenue Year on Year Growth by Quarter and Year

Sarepta Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
SRPT Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 5.42 1.25 -1.84
III Quarter September - - - 1.06
II Quarter June - - - 2.58
I Quarter March 16.34 - - 6.09
FY   16.34 5.42 1.25 7.89

Financial Statements
Sarepta Therapeutics,'s first quarter 2017 Revenue $ 16.34 millions SRPT's Income Statement
Sarepta Therapeutics,'s first quarter 2016 Revenue $ 0.00 millions Quarterly SRPT's Income Statement
SRPT's Growth by Division See SRPT's Growth by Segment

SRPT Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 333.6 % - -
III Quarter September - - - -74.58 %
II Quarter June - - - -12.54 %
I Quarter March - - - 36.24 %
FY   - 333.6 % -84.16 % -



SRPT Revenue Growth Comment
Sarepta Therapeutics, Inc. in the first quarter achieved Revenue of $ 16.34 millions compare to recorded in same quarter a year ago.

According to the results reported in the first quarter, Sarepta Therapeutics, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Sarepta Therapeutics, Inc.' s Revenue no change of % ranks overall at the positon no. 0 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
332.64 % -7.91 % -100 %
(Dec 31 2016)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SRPT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SRPT's Competitors
Revenue Growth for Sarepta Therapeutics,'s Suppliers
Revenue Growth for SRPT's Customers

You may also want to know
SRPT's Annual Growth Rates SRPT's Profitability Ratios SRPT's Asset Turnover Ratio SRPT's Dividend Growth
SRPT's Roe SRPT's Valuation Ratios SRPT's Financial Strength Ratios SRPT's Dividend Payout Ratio
SRPT's Roa SRPT's Inventory Turnover Ratio SRPT's Growth Rates SRPT's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Utah Medical Products Inc -0.41 %$ -0.408 millions
Livanova Plc -0.65 %$ -0.650 millions
Tearlab Corp -0.98 %$ -0.975 millions
Parexel International Corp -1.01 %$ -1.014 millions
Alliqua Biomedical, Inc. -1.06 %$ -1.055 millions
Spark Therapeutics, Inc. -1.10 %$ -1.099 millions
Amgen Inc. -1.14 %$ -1.140 millions
Zynex Inc -1.18 %$ -1.179 millions
Biolase, Inc -1.24 %$ -1.235 millions
Ligand Pharmaceuticals Inc -1.29 %$ -1.285 millions
Seattle Genetics Inc -1.82 %$ -1.821 millions
Reliv International Inc -1.98 %$ -1.984 millions
Adaptimmune Therapeutics Plc -2.09 %$ -2.090 millions
Wright Medical Group N.v. -2.12 %$ -2.119 millions
Oncomed Pharmaceuticals Inc -2.16 %$ -2.157 millions
Prothena Corp Plc -2.26 %$ -2.264 millions
Antares Pharma, Inc. -2.53 %$ -2.527 millions
Integrated Biopharma Inc -2.89 %$ -2.889 millions
Allied Healthcare Products Inc -2.93 %$ -2.930 millions
Becton Dickinson & Co -3.20 %$ -3.195 millions
Encision Inc -3.36 %$ -3.361 millions
Infusystem Holdings, Inc -3.50 %$ -3.498 millions
Brookdale Senior Living Inc. -3.67 %$ -3.673 millions
Kindred Healthcare, Inc -3.79 %$ -3.785 millions
Tenet Healthcare Corp -4.13 %$ -4.133 millions
Chembio Diagnostics, Inc. -4.18 %$ -4.180 millions
Progenics Pharmaceuticals Inc -4.20 %$ -4.204 millions
Cas Medical Systems Inc -4.23 %$ -4.228 millions
Amphastar Pharmaceuticals, Inc. -4.54 %$ -4.541 millions
Strata Skin Sciences, Inc. -4.57 %$ -4.567 millions